2018年11月22日星期四

Improved glycemic control due to reduction in glucagon levels by the administration of once-weekly dulaglutide in a non-obese patient with type 2 diabetes

Improved glycemic control due to reduction in glucagon levels by the administration of once-weekly dulaglutide in a non-obese patient with type 2 diabetes

S Morimitsu, H Hamasaki - Journal of Endocrinology and Metabolism, 2018 - jofem.org
… Abstract, ▴Top. Treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs) is a
cornerstone for the management of obesity and type 2 diabetes … Keywords: Type 2 diabetes;
Glucagon-like peptide-1 receptor agonist; Glucagon. Introduction, ▴Top …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论